BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37474918)

  • 21. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.
    Temmerman M; Tyndall MW; Kidula N; Claeys P; Muchiri L; Quint W
    Int J Gynaecol Obstet; 1999 May; 65(2):171-81. PubMed ID: 10405062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of high-risk human papillomavirus and cervical lesion risk factors: A population-based study in Zhejiang, China 2010-2019.
    Lu W; Chen T; Yao Y; Chen P
    J Med Virol; 2021 Aug; 93(8):5118-5125. PubMed ID: 33913528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
    Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
    Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of human papillomavirus among women with abnormal cervical cytology in Kuwait.
    Al-Awadhi R; Chehadeh W; Jaragh M; Al-Shaheen A; Sharma P; Kapila K
    Diagn Cytopathol; 2013 Feb; 41(2):107-14. PubMed ID: 21987449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.
    Keller MJ; Burk RD; Xie X; Anastos K; Massad LS; Minkoff H; Xue X; D'Souza G; Watts DH; Levine AM; Castle PE; Colie C; Palefsky JM; Strickler HD
    JAMA; 2012 Jul; 308(4):362-9. PubMed ID: 22820789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple HPV infections among men who have sex with men engaged in anal cancer screening in Abuja, Nigeria.
    Nowak RG; Schumaker LM; Ambulos NP; Ndembi N; Dauda W; Nnaji CH; Mitchell A; Mathias TJ; Jibrin P; Darragh TM; Olaomi O; Crowell TA; Baral SD; Charurat ME; Bentzen SM; Palefsky JM; Cullen KJ;
    Papillomavirus Res; 2020 Dec; 10():100200. PubMed ID: 32492573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
    Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiota dysbiosis is associated with HPV-induced cervical carcinogenesis.
    Kwasniewski W; Wolun-Cholewa M; Kotarski J; Warchol W; Kuzma D; Kwasniewska A; Gozdzicka-Jozefiak A
    Oncol Lett; 2018 Dec; 16(6):7035-7047. PubMed ID: 30546437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.
    Wheeler CM; Hunt WC; Cuzick J; Langsfeld E; Robertson M; Castle PE;
    Int J Cancer; 2014 Aug; 135(3):624-34. PubMed ID: 24226935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria.
    Daniel GO; Musa J; Akindigh TM; Shinku F; Shuaibu SI; Kwaghe B; Afolaranmi T; Okpala C; Agbaji O; Sagay A
    Int J Gynaecol Obstet; 2020 Nov; 151(2):253-259. PubMed ID: 32683675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
    Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
    Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into the vaginal microbiome in a diverse group of women of African, Asian and European ancestries.
    Roachford OSE; Alleyne AT; Nelson KE
    PeerJ; 2022; 10():e14449. PubMed ID: 36518275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study.
    Ciavattini A; Serri M; Di Giuseppe J; Liverani CA; Gardella B; Papiccio M; Delli Carpini G; Morini S; Clemente N; Sopracordevole F
    BMJ Open; 2019 Jul; 9(7):e024920. PubMed ID: 31272971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and viral load of 51 genital human papillomavirus types and three subtypes.
    Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Arbyn M; Pawlita M;
    Int J Cancer; 2013 May; 132(10):2395-403. PubMed ID: 23034864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
    Metz CK; Skof AS; Sehouli J; Siedentopf JP; Gebert P; Weiss F; Alba Alejandre I; Heinrich-Rohr M; Weizsaecker K; Henrich W; Kaufmann AM; Rohr I
    Arch Gynecol Obstet; 2023 Jul; 308(1):207-218. PubMed ID: 36576558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.